Novelix Pharmaceuticals Ltd Completes Two Significant Equity Allotments, Increasing Capital Base
Novelix Pharmaceuticals Ltd announced the completion of two separate equity allotment events on July 9, 2026. The company issued shares through both a preferential issue to Promoter and Promoter Group members following warrant conversion, and a subsequent preferential issue to non-promoter investors. These transactions resulted in a notable increase in the company's paid up equity capital.
The first transaction involved the allotment of 33,75,000 equity shares upon conversion of warrants available to promoter category individuals. The stock was allotted at an issue price of Rs 20 each, which included a premium of Rs 10 per share and had a face value of Rs 10.
The details of the allottees for this transaction are as follows:
| Sr. No | Name of Allottee | Number of Equity Shares Allotted |
|---|---|---|
| Strategic Investors (Promoter and Promoter Group) | SRINIDHI FINE CHEMICALS LLP | 2,00,000 |
| NARAHARI BELIDE | 4,00,000 | |
| VUPPARAPALLI CHANDRASEKHAR REDDY | 7,75,000 | |
| NEHA GATTU | 1,00,000 | |
| Total | 33,75,000 |
The company received Rs 50,625,000.00 against the allotment of these shares. Prior to this transaction, the paid up equity capital stood at Rs 238,950,000.00, consisting of 23,895,000 Equity Shares. Following the conversion and allotment, the paid up equity capital increased to Rs 27,27,00,000.00, comprising 27,270,000 Equity Shares.
The second transaction involved a preferential issue of equity shares to non-promoter investors totaling 12,00,000 shares. These shares were issued at an issue price of Rs 57 each, which reflected a face value of Rs 10 and a premium of Rs 47 per share. The company received Rs 6,84,00,000.00 as consideration for the allotment of these shares.
The list of non-promoter allottees is detailed below:
| Sr. No | Name of Allottee | Number of Equity Shares Allotted |
|---|---|---|
| Strategic Investors (Non-Promoters) | PEDDI SRIDHAR | 1,00,000 |
| PALAKURTHI RAKESH | 1,00,000 | |
| RAHUL INNANI | 3,00,000 | |
| SUMAN RAJIV BIHANI | 1,00,000 | |
| VEDANI RAJIV BHIJANI | 1,00,000 | |
| PRAKASH GALDA | 1,00,000 | |
| K VARSHA | 50,000 | |
| VIJAYA SURESH NIMBALE | 25,000 | |
| PRASANTH SOWMITHRY BRUNDAVANAM | 25,000 | |
| T PRAVEEN KUMAR | 1,10,000 | |
| ALLADI PRAVEEN | 50,000 | |
| GANGADHAR KATHURI | 10,000 | |
| RA.IFNDF,R BEIJIDF | 3,00,000 | |
| BELIDE VIJAYALAKSHMI | 1,00,000 | |
| VENKATRAMANA MANUSANI | 50,000 | |
| MANUSANI JALAJA LAXMI | 50,000 | |
| Total | 12,00,000 |
Following the allotment of these shares to non-promoter investors, the paid up equity capital of Novelix Pharmaceuticals Ltd increased from Rs 27,27,00,000.00 to Rs 28,47,00,000.00.
Stock Price Movement
Novelix Pharmaceuticals Ltd. settled at ₹66.71 on Thursday, dropping 4.01% as the stock closed for the day. The shares traded within a range defined by an intraday low of ₹66.03 and a high of ₹71.23.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.